Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood cancer journal (New York) 2020-10, Vol.10 (10), p.104-104, Article 104
Hauptverfasser:	Tsui, Sze P., Ip, Ho W., Saw, Nicole Y., Zhang, Chunxiao, Cheung, Arthur K., Ng, Nelson K., Man, Cheuk H., Lam, Stephen S., Tang, Wing F., Lin, Chi H., Cheng, Grace H., Au, Chun H., Ma, Edmond S., Chan, Tsun L., So, Jason C., Ng, Margaret H., Cheng, Kelvin C., Wong, Kit F., Siu, Lai P., Yip, Sze F., Lin, Shek Y., Lau, June S., Luk, Tsan H., Lee, Harold K., Lau, Chi K., Kho, Bonnie, Sim, Joycelyn P., Kwong, Yok L., Leung, Suet Y., Javed, Asif, Leung, Anskar Y.
Format:	Artikel
Sprache:	eng
Schlagworte:	45/22 45/23 631/208/2489/144/68 631/67/1990/283/1897 Adolescent Adult Aged Antineoplastic Combined Chemotherapy Protocols - administration & dosage Biomedical and Life Sciences Biomedicine Cancer Research Correspondence Disease-Free Survival Female Hematology Humans Idarubicin - administration & dosage Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - genetics Leukemia, Myeloid, Acute - mortality Male Middle Aged Mitoxantrone - administration & dosage Oncology Survival Rate Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!